Evaluation of Postoperative Nausea and Vomiting Incidence in Patients With Mastectomy Surgery According to Apfel Risk Scoring System

NCT04986722 | Completed

• 1 other identifier: G-5097-2019
• Study Type: observational
• Target: 57
• Locations: 1 country
• Sites: 1

Brief Summary

Objective: To evaluate the symptoms of postoperative nausea and vomiting (PONV) in patients undergoing mastectomy with breast cancer according to the Apfel Risk Scoring System. Materials and Methods: The descriptive and cross-sectional study was conducted between June 2020 and August 2020 in the surgical oncology department of a tertiary hospital. A total of 57 female patients who were scheduled for surgical treatment for breast cancer were included in the study. Data including demographic and clinical characteristics of the patients were recorded by face-to-face interview method. The incidence of PONV was evaluated using the Patient Evaluation Form and the Apfel Risk Scoring System.

Conditions

Surgery

Outcome Measures

Primary Outcomes (1)

• Evaluation of the Apfel risk score before surgery

  Apfel Risk Scoring ; It is a tool in which the patient's previous postoperative nausea, vomiting and/or motion sickness history, non-smoking status, and postoperative opioid use are questioned to assess the patient's postoperative nausea and vomiting (PONV) risk score. The patient is evaluated with the Apfel Risk Score preoperatively. As a result of the evaluation, the patient is considered 0-1 point low risk, 2 points medium risk, and ≥3-4 points high risk for PONV.

  Preoperative 0-1 days

Secondary Outcomes (1)

• Evaluation of postoperative nausea and vomiting

  Postoperative 0-2 days

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: female patients scheduled for mastectomy
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

\- Patients diagnosed with breast cancer, female, scheduled for mastectomy, over 18 years of age and who agreed to participate in the study were included in the study.

You may qualify if:

• Diagnosed with breast cancer,
• Have female gender,
• Mastectomy planned

You may not qualify if:

• Having speech, comprehension and language barriers
• Who do not agree to participate in the study,
• Patients with male gender

Sponsors & Collaborators

• Cukurova University: lead

Study Sites (1)

Cukurova University

Adana, 01130, Turkey (Türkiye)

Location

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 10, 2021
• First Posted: August 3, 2021
• Study Start: June 1, 2020
• Primary Completion: August 31, 2020
• Study Completion: August 31, 2020
• Last Updated: August 3, 2021

Record last verified: 2021-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)